# Dolutegravir Sodium / Lamivudine Tablets (ドウベイト配合錠)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6250119F1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6250119F1029
- **Product name (Japanese):** ドウベイト配合錠
- **English title:** Dolutegravir Sodium / Lamivudine Tablets
- **Active ingredient:** ドルテグラビルナトリウム・ラミブジン
- **Active ingredient (INN):** Dolutegravir Sodium / Lamivudine
- **Strength / unit:** １錠
- **Route:** Oral (内用薬)
- **Therapeutic category:** 62 Chemotherapeutics (化学療法剤) › 625 Antivirals (抗ウイルス剤)
- **Manufacturer:** ヴィーブヘルスケア
- **NHI price (reference only):** JPY 4792 per １錠
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6250119F1029
- **JSON:** https://www.nifujipharma.com/api/drugs/6250119F1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Dolutegravir%20Sodium%20%2F%20Lamivudine%20Tablets%20(%E3%83%89%E3%82%A6%E3%83%99%E3%82%A4%E3%83%88%E9%85%8D%E5%90%88%E9%8C%A0)%20%2F%20YJ%206250119F1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.